Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
1962 2
1963 1
1964 2
1965 4
1966 3
1967 8
1968 12
1969 4
1970 6
1971 3
1972 8
1973 6
1974 7
1975 1
1976 7
1977 7
1978 12
1979 13
1980 11
1981 14
1982 17
1983 28
1984 17
1985 29
1986 38
1987 25
1988 41
1989 35
1990 31
1991 45
1992 36
1993 57
1994 62
1995 56
1996 38
1997 53
1998 31
1999 37
2000 35
2001 46
2002 53
2003 50
2004 47
2005 51
2006 55
2007 55
2008 57
2009 65
2010 63
2011 57
2012 52
2013 73
2014 81
2015 76
2016 68
2017 66
2018 83
2019 64
2020 85
2021 90
2022 60
Text availability
Article attribute
Article type
Publication date

Search Results

2,095 results
Results by year
Filters applied: . Clear all
Page 1
Trifluridine/tipiracil versus placebo in patients with heavily pretreated metastatic gastric cancer (TAGS): a randomised, double-blind, placebo-controlled, phase 3 trial.
Shitara K, Doi T, Dvorkin M, Mansoor W, Arkenau HT, Prokharau A, Alsina M, Ghidini M, Faustino C, Gorbunova V, Zhavrid E, Nishikawa K, Hosokawa A, Yalçın Ş, Fujitani K, Beretta GD, Cutsem EV, Winkler RE, Makris L, Ilson DH, Tabernero J. Shitara K, et al. Among authors: nishikawa k. Lancet Oncol. 2018 Nov;19(11):1437-1448. doi: 10.1016/S1470-2045(18)30739-3. Epub 2018 Oct 21. Lancet Oncol. 2018. PMID: 30355453 Clinical Trial.
SLPI is a critical mediator that controls PTH-induced bone formation.
Morimoto A, Kikuta J, Nishikawa K, Sudo T, Uenaka M, Furuya M, Hasegawa T, Hashimoto K, Tsukazaki H, Seno S, Nakamura A, Okuzaki D, Sugihara F, Ninomiya A, Yoshimura T, Takao-Kawabata R, Matsuda H, Ishii M. Morimoto A, et al. Among authors: nishikawa k. Nat Commun. 2021 Apr 9;12(1):2136. doi: 10.1038/s41467-021-22402-x. Nat Commun. 2021. PMID: 33837198 Free PMC article.
Phase III study comparing oxaliplatin plus S-1 with cisplatin plus S-1 in chemotherapy-naïve patients with advanced gastric cancer.
Yamada Y, Higuchi K, Nishikawa K, Gotoh M, Fuse N, Sugimoto N, Nishina T, Amagai K, Chin K, Niwa Y, Tsuji A, Imamura H, Tsuda M, Yasui H, Fujii H, Yamaguchi K, Yasui H, Hironaka S, Shimada K, Miwa H, Hamada C, Hyodo I. Yamada Y, et al. Among authors: nishikawa k. Ann Oncol. 2015 Jan;26(1):141-148. doi: 10.1093/annonc/mdu472. Epub 2014 Oct 14. Ann Oncol. 2015. PMID: 25316259 Free article. Clinical Trial.
Safety and activity of trifluridine/tipiracil and ramucirumab in previously treated advanced gastric cancer: an open-label, single-arm, phase 2 trial.
Kawazoe A, Ando T, Hosaka H, Fujita J, Koeda K, Nishikawa K, Amagai K, Fujitani K, Ogata K, Watanabe K, Yamamoto Y, Shitara K. Kawazoe A, et al. Among authors: nishikawa k. Lancet Gastroenterol Hepatol. 2021 Mar;6(3):209-217. doi: 10.1016/S2468-1253(20)30396-4. Epub 2021 Jan 26. Lancet Gastroenterol Hepatol. 2021. PMID: 33508242 Clinical Trial.
In Response.
Tsujikawa S, Matsuura T, Hori K, Mori T, Kuno M, Nishikawa K. Tsujikawa S, et al. Among authors: nishikawa k. Anesth Analg. 2018 Jun;126(6):2148. doi: 10.1213/ANE.0000000000002884. Anesth Analg. 2018. PMID: 29517570 No abstract available.
Randomized, Phase II Study of Trastuzumab Beyond Progression in Patients With HER2-Positive Advanced Gastric or Gastroesophageal Junction Cancer: WJOG7112G (T-ACT Study).
Makiyama A, Sukawa Y, Kashiwada T, Kawada J, Hosokawa A, Horie Y, Tsuji A, Moriwaki T, Tanioka H, Shinozaki K, Uchino K, Yasui H, Tsukuda H, Nishikawa K, Ishida H, Yamanaka T, Yamazaki K, Hironaka S, Esaki T, Boku N, Hyodo I, Muro K. Makiyama A, et al. Among authors: nishikawa k. J Clin Oncol. 2020 Jun 10;38(17):1919-1927. doi: 10.1200/JCO.19.03077. Epub 2020 Mar 24. J Clin Oncol. 2020. PMID: 32208960 Clinical Trial.
Emphysematous gastritis.
Shibata M, Tsuchiya A, Nishikawa K. Shibata M, et al. Among authors: nishikawa k. Oxf Med Case Reports. 2020 Dec 28;2020(12):omaa114. doi: 10.1093/omcr/omaa114. eCollection 2020 Dec. Oxf Med Case Reports. 2020. PMID: 33391770 Free PMC article. No abstract available.
Hemangioma of the Small Intestine.
Shibata M, Tsuchiya A, Nishikawa K. Shibata M, et al. Among authors: nishikawa k. Am J Med Sci. 2021 Dec;362(6):e55-e56. doi: 10.1016/j.amjms.2021.05.008. Epub 2021 May 17. Am J Med Sci. 2021. PMID: 34010621 No abstract available.
Nab-paclitaxel versus solvent-based paclitaxel in patients with previously treated advanced gastric cancer (ABSOLUTE): an open-label, randomised, non-inferiority, phase 3 trial.
Shitara K, Takashima A, Fujitani K, Koeda K, Hara H, Nakayama N, Hironaka S, Nishikawa K, Makari Y, Amagai K, Ueda S, Yoshida K, Shimodaira H, Nishina T, Tsuda M, Kurokawa Y, Tamura T, Sasaki Y, Morita S, Koizumi W. Shitara K, et al. Among authors: nishikawa k. Lancet Gastroenterol Hepatol. 2017 Apr;2(4):277-287. doi: 10.1016/S2468-1253(16)30219-9. Epub 2017 Jan 19. Lancet Gastroenterol Hepatol. 2017. PMID: 28404157 Clinical Trial.
Muscle Function from Organisms to Molecules.
Nishikawa KC, Monroy JA, Tahir U. Nishikawa KC, et al. Integr Comp Biol. 2018 Aug 1;58(2):194-206. doi: 10.1093/icb/icy023. Integr Comp Biol. 2018. PMID: 29850810 Review.
2,095 results